{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:27:07Z","timestamp":1794637627787,"version":"4.9.1"},"reference-count":25,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>KRAS G12C is a treatment-defining biomarker in non\u2013small cell lung cancer (NSCLC), particularly lung adenocarcinoma. Hispanic\/Latino (H\/L) patients remain undercharacterized in precision oncology datasets, and patient-level KRAS G12C prevalence has not been consistently quantified using strict ethnicity definitions. We analyzed MSK-CHORD as the initial reference cohort and American Association for Cancer Research (AACR) GENIE after excluding the Memorial Sloan Kettering Cancer Center contributing center. H\/L required explicit H\/L-origin annotation; non-Hispanic White (NH-W) required White race with explicit non-Hispanic ethnicity. Primary analyses compared patient-level KRAS G12C prevalence in mutually exclusive lung adenocarcinoma and non\u2013lung adenocarcinoma NSCLC. In lung adenocarcinoma, KRAS G12C prevalence was lower in H\/L than NH-W patients in MSK-CHORD [7.9% vs. 15.4%; odds ratio (OR), 0.47; 95% confidence interval (CI), 0.30\u20130.74; P &amp;lt; 0.001] and GENIE (7.2% vs. 15.1%; OR, 0.44; 95% CI, 0.33\u20130.58; P &amp;lt; 0.0001). In non\u2013lung adenocarcinoma NSCLC, differences were smaller and not significant in MSK-CHORD (4.8% vs. 5.1%; OR, 0.94; P = 1) or GENIE (4.9% vs. 6.7%; OR, 0.73; P = 0.461). In MSK-CHORD lung adenocarcinoma, adjustment for smoking shifted the OR from 0.50 to 0.68. H\/L patients had lower patient-level KRAS G12C prevalence than NH-W patients with lung adenocarcinoma across two real-world clinicogenomic cohorts. The finding was histology specific and attenuated after smoking adjustment, supporting a biomarker-yield interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>H\/L patients remain undercharacterized in real-world precision oncology datasets. This study provides patient-level, histology-specific estimates of KRAS G12C prevalence among H\/L and NH-W patients using strict race\/ethnicity definitions, coverage-aware denominators, and two large clinicogenomic cohorts. These findings inform biomarker screening yield in lung adenocarcinoma and support more rigorous, population-aware evaluation of actionable alterations in real-world oncology datasets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0322","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:50:42Z","timestamp":1787694642000},"page":"2090-2097","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-Level\n                    <i>KRAS<\/i>\n                    G12C Prevalence among Hispanic\/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-0498","authenticated-orcid":false,"given":"Daniel F.","family":"Pilco-Janeta","sequence":"first","affiliation":[{"name":"1Latin American Institute of Precision Oncology (CancerLat), Quito, Ecuador."},{"name":"2Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-0974","authenticated-orcid":false,"given":"Myriam","family":"De la Cruz-Puebla","sequence":"additional","affiliation":[{"name":"1Latin American Institute of Precision Oncology (CancerLat), Quito, Ecuador."},{"name":"3Department of Internal Medicine, Health Sciences Faculty, Technical University of Ambato, Ambato, Ecuador."},{"id":[{"id":"https:\/\/ror.org\/043mz5j54","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, San Francisco (UCSF) 4 Atlantic Fellows for Equity in Brain Health, , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9212-0872","authenticated-orcid":false,"given":"Daisy R.","family":"Guam\u00e1n-Pilco","sequence":"additional","affiliation":[{"name":"1Latin American Institute of Precision Oncology (CancerLat), Quito, Ecuador."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5656-6061","authenticated-orcid":false,"given":"Diego","family":"Montenegro","sequence":"additional","affiliation":[{"name":"1Latin American Institute of Precision Oncology (CancerLat), Quito, Ecuador."},{"name":"5Department of Oncology, Oncology Institute of Eastern Bolivia, Santa Cruz, Bolivia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5342-4235","authenticated-orcid":false,"given":"William","family":"Miranda","sequence":"additional","affiliation":[{"name":"6Department of Health Services, Ministry of Public Health, Managua, Nicaragua."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026111400414971000_bib1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"2026111400414971000_bib2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"2026111400414971000_bib3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1158\/1078-0432.CCR-17-1841","article-title":"Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer","volume":"24","author":"Arbour","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026111400414971000_bib4","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1158\/1078-0432.CCR-20-4023","article-title":"Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer","volume":"27","author":"Arbour","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2026111400414971000_bib5","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for lung cancers with KRAS p.G12C mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N Engl J Med"},{"key":"2026111400414971000_bib6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2204619","article-title":"Adagrasib in non-small-cell lung cancer harboring a KRASG12C mutation","volume":"387","author":"J\u00e4nne","year":"2022","journal-title":"N Engl J Med"},{"key":"2026111400414971000_bib7","doi-asserted-by":"publisher","first-page":"946625","DOI":"10.3389\/fonc.2022.946625","article-title":"Genomic landscape of lung adenocarcinomas in different races","volume":"12","author":"Shi","year":"2022","journal-title":"Front Oncol"},{"key":"2026111400414971000_bib8","doi-asserted-by":"publisher","first-page":"101276","DOI":"10.1016\/j.tranon.2021.101276","article-title":"p.G12C KRAS mutation prevalence in non-small cell lung cancer: contribution from interregional variability and population substructures among Hispanics","volume":"15","author":"Ruiz-Pati\u00f1o","year":"2022","journal-title":"Transl Oncol"},{"key":"2026111400414971000_bib9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1056\/NEJMc2030638","article-title":"Distribution of KRAS G12C somatic mutations across race, sex, and cancer type","volume":"384","author":"Nassar","year":"2021","journal-title":"N Engl J Med"},{"key":"2026111400414971000_bib10","doi-asserted-by":"publisher","first-page":"100320","DOI":"10.1016\/j.xhgg.2024.100320","article-title":"Additional impact of genetic ancestry over race\/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer","volume":"5","author":"Wang","year":"2024","journal-title":"HGG Adv"},{"key":"2026111400414971000_bib11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"AACR Project GENIE Consortium","year":"2017","journal-title":"Cancer Discov"},{"key":"2026111400414971000_bib12","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/2159-8290.CD-21-1547","article-title":"AACR Project GENIE: 100,000 cases and beyond","volume":"12","author":"Pugh","year":"2022","journal-title":"Cancer Discov"},{"key":"2026111400414971000_bib13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-024-08167-5","article-title":"Automated real-world data integration improves cancer outcome prediction","volume":"636","author":"Jee","year":"2024","journal-title":"Nature"},{"key":"2026111400414971000_bib14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2026111400414971000_bib15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/CAD.0000000000001801","article-title":"The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategies","volume":"37","author":"Pilco-Janeta","year":"2026","journal-title":"Anticancer Drugs"},{"key":"2026111400414971000_bib16","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1158\/1078-0432.CCR-21-3074","article-title":"FDA approval summary: sotorasib for KRAS G12C-mutated metastatic NSCLC","volume":"28","author":"Nakajima","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2026111400414971000_bib17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40265-023-01839-y","article-title":"Adagrasib: first approval","volume":"83","author":"Dhillon","year":"2023","journal-title":"Drugs"},{"key":"2026111400414971000_bib18","doi-asserted-by":"publisher","first-page":"107293","DOI":"10.1016\/j.lungcan.2023.107293","article-title":"KRAS G12C in advanced NSCLC: prevalence, co-mutations, and testing","volume":"184","author":"Lim","year":"2023","journal-title":"Lung Cancer"},{"key":"2026111400414971000_bib19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jtho.2017.08.019","article-title":"Somatic mutations and ancestry markers in Hispanic lung cancer patients","volume":"12","author":"Gimbrone","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2026111400414971000_bib20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1158\/2159-8290.CD-20-1165","article-title":"Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations","volume":"11","author":"Carrot-Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"2026111400414971000_bib21","doi-asserted-by":"publisher","first-page":"107378","DOI":"10.1016\/j.lungcan.2023.107378","article-title":"Prevalence of oncogenic driver mutations in Hispanics\/Latin patients with lung cancer. A systematic review and meta-analysis","volume":"185","author":"Parra-Medina","year":"2023","journal-title":"Lung Cancer"},{"key":"2026111400414971000_bib22","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1158\/0008-5472.CAN-20-3991","article-title":"Association between smoking history and tumor mutation burden in advanced non-small cell lung cancer","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"2026111400414971000_bib23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3892\/ol.2015.3414","article-title":"Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma","volume":"10","author":"Soh","year":"2015","journal-title":"Oncol Lett"},{"key":"2026111400414971000_bib24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov"},{"key":"2026111400414971000_bib25","doi-asserted-by":"publisher","first-page":"e0307580","DOI":"10.1371\/journal.pone.0307580","article-title":"Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma","volume":"19","author":"Liang","year":"2024","journal-title":"PLoS One"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0322\/3824742\/crc-26-0322.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/9\/2090\/3827362\/crc-26-0322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/9\/2090\/3827362\/crc-26-0322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:41:58Z","timestamp":1794634918000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/9\/2090\/787843\/Patient-Level-KRAS-G12C-Prevalence-among-Hispanic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0322","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.33453694","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453733","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453721","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453703","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453745","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009414","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009426","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453739","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009402","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453727","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009432","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009420","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453709","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009408","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009438","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453700","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453742","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453697","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453730","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453748","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453736","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453724","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453712","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453718","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009423","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33453706","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009435","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009411","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009441","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009429","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009405","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.35009417","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8696779","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}